Subscribe to news

Press Center

25.07.2017
PJSC HSCI, today announced that its US Licensee, Artgen, Inc., has been selected to receive a collaborative MIPS award with the University of Maryland to advance the development of a gene-therapy drug candidate for the treatment of Peripheral Arterial Disease (PAD).
21.06.2017
PJSC “HSCI” – The Human Stem Cells Institute today announced the results of its Annual General Shareholders’ Meeting (AGM) held on June 21, 2017 in Moscow.
09.06.2017
PJSC HSCI, today announced its unaudited consolidated interim results for the first quarter of 2017 in accordance with the International Financial Reporting Standards (IFRS).
07.06.2017
The Human Stem Cells Institute, today announced that its subsidiary, GENETICO LLC, has launched Russia’s first specialized laboratory to conduct a full cycle of non-invasive prenatal testing (NIPT) based on Ariosa Diagnostics' Harmony™ technology.
18.05.2017
The Human Stem Cells Institute, today announced the decisions of the Company’s Board of Directors on the agenda of the Annual General Shareholders’ Meeting (hereinafter – AGM) upon the results of FY2016.
28.04.2017
PJSC “HSCI” today announced its audited consolidated results for the full year 2016 in accordance with the International Financial Reporting Standards (IFRS).
26.04.2017
The Human Stem Cells Institute, today announced the decisions of the Company’s Board of Directors on convocation of the Annual General Shareholders’ Meeting upon the results of FY2016.
22.12.2016
Human Stem Cells Institute Becomes a Stockholder in Artgen, Inc.
09.12.2016
HSCI Announces 9mo 2016 Consolidated Results under IFRS